ProCE Banner Activity

Exploring New Diagnostic and Therapeutic Possibilities in Chronic Spontaneous Urticaria

Slideset Download

Download these slides for an expert review of the diagnosis and treatment, including current and promising investigational therapies, for chronic spontaneous urticaria.

Released: September 09, 2022



Jonathan A. Bernstein

Jonathan A. Bernstein, MD

Professor of Medicine
University of Cincinnati College of Medicine
Department of Internal Medicine
Division of Rheumatology, Allergy and Immunology
Partner Bernstein Allergy Group and Bernstein Clinical Research Center
Cincinnati, Ohio

Provided by

ProCE Banner
ProCE Banner


Supported by educational grants from Novartis Pharmaceuticals Corporation and Sanofi and Regeneron Pharmaceuticals.

Novartis Pharmaceuticals Corporation

Sanofi and Regeneron Pharmaceuticals


Jonathan A. Bernstein, MD: consultant/advisor/speaker: AstraZeneca, Genentech, Novartis, Sanofi/Regeneron; researcher: Allakos, Amgen, AstraZeneca, Celldex, Genentech, Sanofi/Regeneron, TLL

Additional Information

Program Medium

This program has been made available online.